Bottom line
XLV vs SHSSX: the short answer
XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and SHSSX (Blackrock Health Sciences Opportunities Portfolio) share a meaningful slice of their top holdings — about 78% by weight.
But SHSSX is far broader, holding 155 positions to 65 for XLV, so beyond the top names it adds exposure XLV doesn't have.
XLV is cheaper at 0.08% vs 0.86% — a difference of $78 a year per $10,000 invested.
Over five years, XLV returned +8.1% a year vs +5.9% for SHSSX.
Updated Nov 19, 2026
XLV vs SHSSX side by side
| XLV | SHSSX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | SPDR (State Street) | BlackRock |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.08% | 0.86% |
| Annual cost per $10k | $8 | $86 |
| 10-yr cost on $10k (prospectus) | $103 | $1,061 |
| Max front load | None | 0% |
| 12b-1 fee | 0.02% | 0% |
| 1-yr return | +14.5% | +16.3% |
| 5-yr return (annualized) | +8.1% | +5.9% |
| 10-yr return (annualized) | +9.8% | +9.8% |
| Best quarter | +14.5% | — |
| Worst quarter | −12.7% | — |
| Net assets (fund) | $40.6B | $5.9B |
| Number of holdings | 65 | 155 |
| Portfolio turnover | 2% | 49% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
17 of XLV's top 25 holdings also appear in SHSSX's top 25.
| Holding | XLV | SHSSX |
|---|---|---|
| Eli Lilly & Co | 16.51% | 12.29% |
| Johnson & Johnson | 10.64% | 8.77% |
| AbbVie Inc | 7.74% | 3.94% |
| UnitedHealth Group Inc | 6.57% | 6.10% |
| Merck & Co Inc | 5.52% | 4.94% |
| Amgen Inc | 3.40% | 3.37% |
| Thermo Fisher Scientific Inc | 3.24% | 3.02% |
| Abbott Laboratories | 2.75% | 1.97% |
| Gilead Sciences Inc | 2.73% | 4.19% |
| Intuitive Surgical Inc | 2.45% | 1.95% |
| Pfizer Inc | 2.39% | 2.61% |
| Vertex Pharmaceuticals Inc | 2.19% | 2.74% |
| Danaher Corp | 2.09% | 2.00% |
| Stryker Corp | 1.89% | 1.15% |
| Elevance Health Inc | 1.46% | 1.56% |
Source: SEC Form N-PORT
XLV top 10
- Eli Lilly & Co — 16.51%
- Johnson & Johnson — 10.64%
- AbbVie Inc — 7.74%
- UnitedHealth Group Inc — 6.57%
- Merck & Co Inc — 5.52%
- Amgen Inc — 3.40%
- Thermo Fisher Scientific Inc — 3.24%
- Abbott Laboratories — 2.75%
- Gilead Sciences Inc — 2.73%
- Intuitive Surgical Inc — 2.45%
SHSSX top 10
- Eli Lilly & Company — 12.29%
- Johnson & Johnson — 8.77%
- Unitedhealth Group Inc — 6.10%
- Merck & Company Inc — 4.94%
- Gilead Sciences Inc — 4.19%
- Abbvie Inc — 3.94%
- Amgen Inc — 3.37%
- Thermo Fisher Scientific Inc — 3.02%
- Vertex Pharmaceuticals Inc — 2.74%
- Pfizer Inc — 2.61%
FAQ
What is the difference between XLV and SHSSX?
Which is cheaper, XLV or SHSSX?
Should I own both XLV and SHSSX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.